Efficacy and safety of pegylated interferon plus ribavirin for the treatment of hepatitis C virus-positive cryoglobulinemic glomerulonephritis

Cesare Mazzaro, Giacomo Panarello, Endri Mauro, Valter Gattei, Gabriele Pozzato

Research output: Contribution to journalArticle

Abstract

Background: The most frequent form of renal involvement in patients with hepatitis C infection is cryoglobulinemic membrano-proliferative glomerulonephritis. Nonetheless, some reports indicate that the eradication of the hepatitis C virus may also lead to the remission of this renal disease. Methods: The virological, immunological and nephrological response to pegylated interferon α plus ribavirin (48 weeks in patients infected with genotype 1, and 24 weeks for patients infected with genotypes 2 and 3) was evaluated retrospectively in 10 patients with cryoglobulinemic glomerulonephritis. Results: 6 patients obtained end of treatment virological response (60%); during follow-up, 2 relapsed, and 4 patients maintained a sustained virological response (40%). At the end of follow-up, three patients obtained a significant nephrological response and decrease in cryoglobulin levels (p<0.05). No significant changes in clinical and biological parameters were observed in non-responders/relapsers. Conclusions: Eradication of hepatitis C may be associated with the regression of cryoglobulinemic glomerulonephritis.

Original languageEnglish
Pages (from-to)613-616
Number of pages4
JournalDigestive and Liver Disease
Volume47
Issue number7
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Ribavirin
Glomerulonephritis
Hepacivirus
Interferons
Safety
Hepatitis C
Therapeutics
Genotype
Cryoglobulins
Kidney
Infection

Keywords

  • HCV-genotype
  • Hepatitis C virus
  • Membrano-proliferative glomerulo-nephritis

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Efficacy and safety of pegylated interferon plus ribavirin for the treatment of hepatitis C virus-positive cryoglobulinemic glomerulonephritis. / Mazzaro, Cesare; Panarello, Giacomo; Mauro, Endri; Gattei, Valter; Pozzato, Gabriele.

In: Digestive and Liver Disease, Vol. 47, No. 7, 01.07.2015, p. 613-616.

Research output: Contribution to journalArticle

@article{a31b4799c2b14ddabe1d7ea34ddf04ea,
title = "Efficacy and safety of pegylated interferon plus ribavirin for the treatment of hepatitis C virus-positive cryoglobulinemic glomerulonephritis",
abstract = "Background: The most frequent form of renal involvement in patients with hepatitis C infection is cryoglobulinemic membrano-proliferative glomerulonephritis. Nonetheless, some reports indicate that the eradication of the hepatitis C virus may also lead to the remission of this renal disease. Methods: The virological, immunological and nephrological response to pegylated interferon α plus ribavirin (48 weeks in patients infected with genotype 1, and 24 weeks for patients infected with genotypes 2 and 3) was evaluated retrospectively in 10 patients with cryoglobulinemic glomerulonephritis. Results: 6 patients obtained end of treatment virological response (60{\%}); during follow-up, 2 relapsed, and 4 patients maintained a sustained virological response (40{\%}). At the end of follow-up, three patients obtained a significant nephrological response and decrease in cryoglobulin levels (p<0.05). No significant changes in clinical and biological parameters were observed in non-responders/relapsers. Conclusions: Eradication of hepatitis C may be associated with the regression of cryoglobulinemic glomerulonephritis.",
keywords = "HCV-genotype, Hepatitis C virus, Membrano-proliferative glomerulo-nephritis",
author = "Cesare Mazzaro and Giacomo Panarello and Endri Mauro and Valter Gattei and Gabriele Pozzato",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.dld.2015.03.020",
language = "English",
volume = "47",
pages = "613--616",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "7",

}

TY - JOUR

T1 - Efficacy and safety of pegylated interferon plus ribavirin for the treatment of hepatitis C virus-positive cryoglobulinemic glomerulonephritis

AU - Mazzaro, Cesare

AU - Panarello, Giacomo

AU - Mauro, Endri

AU - Gattei, Valter

AU - Pozzato, Gabriele

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background: The most frequent form of renal involvement in patients with hepatitis C infection is cryoglobulinemic membrano-proliferative glomerulonephritis. Nonetheless, some reports indicate that the eradication of the hepatitis C virus may also lead to the remission of this renal disease. Methods: The virological, immunological and nephrological response to pegylated interferon α plus ribavirin (48 weeks in patients infected with genotype 1, and 24 weeks for patients infected with genotypes 2 and 3) was evaluated retrospectively in 10 patients with cryoglobulinemic glomerulonephritis. Results: 6 patients obtained end of treatment virological response (60%); during follow-up, 2 relapsed, and 4 patients maintained a sustained virological response (40%). At the end of follow-up, three patients obtained a significant nephrological response and decrease in cryoglobulin levels (p<0.05). No significant changes in clinical and biological parameters were observed in non-responders/relapsers. Conclusions: Eradication of hepatitis C may be associated with the regression of cryoglobulinemic glomerulonephritis.

AB - Background: The most frequent form of renal involvement in patients with hepatitis C infection is cryoglobulinemic membrano-proliferative glomerulonephritis. Nonetheless, some reports indicate that the eradication of the hepatitis C virus may also lead to the remission of this renal disease. Methods: The virological, immunological and nephrological response to pegylated interferon α plus ribavirin (48 weeks in patients infected with genotype 1, and 24 weeks for patients infected with genotypes 2 and 3) was evaluated retrospectively in 10 patients with cryoglobulinemic glomerulonephritis. Results: 6 patients obtained end of treatment virological response (60%); during follow-up, 2 relapsed, and 4 patients maintained a sustained virological response (40%). At the end of follow-up, three patients obtained a significant nephrological response and decrease in cryoglobulin levels (p<0.05). No significant changes in clinical and biological parameters were observed in non-responders/relapsers. Conclusions: Eradication of hepatitis C may be associated with the regression of cryoglobulinemic glomerulonephritis.

KW - HCV-genotype

KW - Hepatitis C virus

KW - Membrano-proliferative glomerulo-nephritis

UR - http://www.scopus.com/inward/record.url?scp=84937640706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937640706&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2015.03.020

DO - 10.1016/j.dld.2015.03.020

M3 - Article

C2 - 25890508

AN - SCOPUS:84937640706

VL - 47

SP - 613

EP - 616

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 7

ER -